Your Health, We Care
Another Name速福达、LuciBal
IndicationsIt is indicated for the treatment of acute uncomplicated influenza in people aged 5 years and older, and for post-exposure prophylaxis of influenza.
Reg No.07 L 1394/25
Inspection NO.1767-23
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
This prescription drug was approved by the FDA in the United States in 2018. It targets the cap-dependent endonuclease of influenza A and B viruses and must be used strictly under medical supervision.
Cap-dependent endonuclease of influenza A and B viruses
Route and frequency of administration for Baloxavir marboxil (Xofluza): Oral, once daily.
The dosage of Baloxavir marboxil (Xofluza) should be adjusted based on the patient's actual condition. For specific details, consult your doctor and follow medical advice.
Recommended reading: Dosage and Administration of Baloxavir marboxil (Xofluza)
Common side effects: Diarrhea, bronchitis, nausea, etc.
Serious side effects: Difficulty breathing, rash, urticaria or blisters, etc.
Reference article: Side Effects of Baloxavir marboxil (Xofluza)
Pregnancy: It is currently unknown whether Baloxavir marboxil (Xofluza) can harm your unborn baby.
Breastfeeding: It is currently unknown whether Baloxavir marboxil (Xofluza) passes into your breast milk.
1. Baloxavir marboxil (Xofluza) may contain inactive ingredients that could cause allergic reactions or other problems.
2. Follow all instructions on the drug label and package. Inform every healthcare provider of all your health conditions, allergies, and all medications you are using.
FDA，2025.05
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
